Get started
TopgOptions

ARDS upside potential

Long
TopgOptions  
NASDAQ:ARDS   None
Trend Analysis Technical Indicators Fundamental Analysis ARDS ardsstock aridis aridispharmaceuticals PHARMA pharmaceuticals pharmastocks Coronavirus (COVID-19) covidvaccine
8
0
trendanalysis indicator fundamental ards ardsstock aridis aridispharmaceuticals pharma pharmaceuticals pharmastocks coronavirus covidvaccine
ARDS Aridis Pharmaceuticals has 2 Phase 3 Clinical Trials for 2022, one Phase 2a study, a fully human monoclonal antibody (mAb) cocktail against COVID and a funding from the Gates Foundation to support development of inhaled formulation technology to deliver cost-effective monoclonal antibodies against influenza and COVID-19.

And the Market Cap is only 23.892Mil.

In my opinion this stock can double in trice anytime, their pipeline is highly undervalued.
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals www.patreon.com/PremiumOptionsSignals
RESULTS www.bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.